
MD, Hematologist @CHUdeLyon | PhD in Immunology & Bioinformatics Myeloid malignancies (AML, MPN, AA, PNH) Looking for Human Endogenous Retroviruses everywhere
Lyon, France
Joined August 2020
- Tweets822
- Following418
- Followers665
- Likes1.2K
Pinned Tweet
Looking for a free open-source software with a user-friendly graphical interface for data analysis? Consider using #StatAid! #RStats
Online version: alcazerv.shinyapps.io/StatAi…
Github: github.com/VincentAlcazer/St…
Paper: joss.theoj.org/papers/10.211…
Vincent Alcazer retweeted
Gorgeous under the microscope, devastating in reality.
A rare presentation of AML-MRC masquerading as Burkitt-like cells with a striking "starry-sky" pattern.
Don't let the aesthetic fool you—the genetics tell a whole different story.
@BloodPortfolio
authors.elsevier.com/a/1nDF2…
Vincent Alcazer retweeted
Triplet therapy in FLT3-mut AML: ready for primetime?
Key study signals👇
• VICEROY (Aza/Ven/Gilt): CRc ~90–91%; 12-mo OS 60–78%; median OS ~22–23 mo
• Aza/Ven/Gilt frontline (n=30): CR+CRi 96%; FLT3-ITD MRD <10⁻⁵ ~65%; 1-yr OS 85%
• HMA/Ven/FLT3i (n=88): Composite response 98%; median OS 28 mo; 3-yr OS 46%
• Dec/Ven/Quiz (n=30): CRc 94%; 1-yr OS 72%, 2-yr OS 60%
#ASH25 #AMLsm #leusm #MedTwitter @AML_Hub @ASH_hematology
In less than a month, the #ASH2025 Annual Meeting 🩸 kicks off!
Our bioinformatics & AI research group 🖥️ will present 3 key studies this year — all bridging machine learning 🤖 and hematology 🔬.
👇 Highlights:
1
177
Menin inhibitors (MENi) are a major therapeutic hope for AML with specific molecular profiles.
🧬We performed transcriptomic profiling of MENi treated pts and identified a response-associated signature, shedding light on resistance mechanisms 🔎
🔗 meetings-api.hematology.org/…
1
1
98
See you in Orlando 🇺🇸 on Dec 5th for more discussions on applied AI 🤖 & bioinformatics 🖥️ in hematology 🩸!
#ASH2025 #Hematology #ArtificialIntelligence #Bioinformatics #AI #Omic #RNAseq
124
The generative era of medical AI @CellPressNews
cell.com/cell/fulltext/S0092…
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
nature.com/articles/s41586-0…
A clinical guide to TP53 mutations in myeloid neoplasms
ashpublications.org/blood/ar…
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
Vincent Alcazer retweeted
‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation
buff.ly/MfNzLff
Monoclonal Gammopathy of Undetermined Significance NEJM
nejm.org/doi/full/10.1056/NE…
2
120
Tumor Lysis Syndrome | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
2
77
TE-PARPi as a precision weapon against hematologic cancers
ashpublications.org/blood/ar…
69
Interferons in health and disease: Cell cell.com/cell/fulltext/S0092…
1
14
1,496
Vincent Alcazer retweeted
How many platelets do I need to perform a safe lumbar puncture in patients with hematologic malignancies? 40 is the new 50!
haematologica.org/article/vi…
Imaging mass cytometry reveals the order of events in the pathogenesis of immune-mediated aplastic anemia
ashpublications.org/blood/ar…
Vincent Alcazer retweeted
How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission ow.ly/VNYF50WBFRq #HowITreat #lymphoidneoplasia #transplantation
Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time - The Lancet Haematology thelancet.com/journals/lanha…

















